Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...
News-Medical.Net on MSN
Med14 protein drives GLP-1 benefits in pancreatic beta cells
GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and ...
Explore the breakthrough therapy that offers hope to cure type 1 diabetes by restoring insulin-producing beta cells ...
The beta cells in our pancreas act as highly sensitive sensors that constantly measure the amount of sugar in our blood. As ...
University of Chicago researchers developed an mRNA nanoparticle system that triggers cells to produce PD-L1 protein, ...
In recent years, we have come to appreciate that loss or dysfunction of insulin-producing islet beta cells underlies virtually all major forms of diabetes mellitus. In type 1 diabetes, beta cells ...
Borrowing a cancer cell’s disguise, scientists shielded insulin-producing cells from attack by the immune system, a breakthrough that could pave the way for targeted type 1 diabetes treatments without ...
On March 16, Prof. James Lo, pharmacology cell and developmental biology, and his team published a study identifying different types of cells in the pancreas, an organ responsible for aiding digestion ...
Lipid nanoparticles deliver mRNA to insulin-producing beta cells, prompting them to express a protective protein that shields them from autoimmune attack.
Add Yahoo as a preferred source to see more of our stories on Google. Alpha cells in the pancreas produce GLP-1, reshaping our understanding of blood sugar control and diabetes care. (CREDIT: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results